These findings indicate that HIST1H4L is a potential target of ERG fusion genes, as also illustrated by our demonstration of direct binding of ERG to the HIST1H4L promoter, but the mechanism whereby it is involved in prostate carcinogenesis is still unknown. The gene discussed is ERG; the disease is male reproductive organ cancer.